|
Apr 19
|
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
Apr 18
|
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
|
|
Apr 18
|
Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
|
|
Apr 18
|
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
|
|
Apr 18
|
Q1 2024 Abbott Laboratories Earnings Call
|
|
Apr 17
|
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
|
|
Apr 17
|
U.S. Stocks Slide On Tech Weakness
|
|
Apr 17
|
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
|
|
Apr 17
|
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
|
|
Apr 17
|
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
|
|
Apr 17
|
Abbott Labs posts Q1 earnings beat
|
|
Apr 17
|
Abbott Labs Stock Is Slipping After Earnings Beat. Here’s Why.
|
|
Apr 17
|
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 17
|
Abbott Laboratories (ABT) Q1 Earnings: Surpasses EPS Estimates and Raises Full-Year Guidance
|
|
Apr 17
|
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
|
|
Apr 17
|
UPDATE 4-Abbott's device sales drive profit beat, but shares fall as forecast disappoints
|
|
Apr 17
|
Abbott's device sales drive profit beat, but shares fall as forecast disappoints
|
|
Apr 17
|
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
|
|
Apr 17
|
Abbott beats quarterly profit estimates on strong medical device sales
|
|
Apr 15
|
Abbott’s latest Heartmate recall tied to 273 injuries, 14 deaths
|